New way to cut heart and stroke risk
The story is about a clinically proven supplement that prevents oxidation of LDL cholesterol, which as you know, is the first step in the build up of atherosclerosis, the main cause of heart attack, stroke – and even circulatory dementia and AMD (age related macular degeneration).
The supplement, medical name Ateronon, is based on lycopene, but whereas other supplements on sale are not bioavailable and haven’t been proved in clinical studies, this one has – so it’s going to be launched in June at the British Cardiovascular Conference for cardiologists at Excel, London.
The feature would be a useful way of reminding readers how their clogged up arteries can have even more consequences than a heart attack (i.e. stroke, AMD, dementia, other diseases of circulation).
But it is also a Good News story, because it is something practical that readers can do to help prevent atherosclerosis in the first place.
The product was developed by a Cambridge University biotechnology spin-off company, and is being referred to in the media as the tomato pill, and in addition to the clinical studies on patients that show more than 90% reduction in oxidation of ‘bad’ cholesterol within 2 months; there are on-going trials at Harvard Uni (re: reversal of atherosclerosis, reduction of hypertension), and at Addenbrooke’s, Cambridge Uni Hosp.
Recent Comments